Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda - PubMed (original) (raw)
Affiliations
- PMID: 9557424
Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda
M Odiit et al. East Afr Med J. 1997 Dec.
Abstract
Although there have been recent molecular biological studies for evidence of possible changes in trypanosome biochemistry, such studies are not yet complemented by parallel clinical studies to determine the possible implications to the sleeping sickness patient. The study of the duration of symptoms and the case fatality of T. b. rhodesiense showed that the disease progressed to the stage of central nervous system involvement between three weeks to two months of infection. Most (> 80%) deaths occurred within six months of illness. The case fatality rate of treated sleeping sickness patients was 6% of which the rate in the late-stage of sleeping sickness was more than two and a half times that in the early stage. The incidence of melarsoprol encephalopathy was 2.5% and case fatality due to this condition was 1.0% and similar to previous findings. Thus it appears the virulence of T. b. rhodesiense circulating in south east Uganda has not changed during the past decades.
Similar articles
- Spatial and temporal risk factors for the early detection of Trypanosoma brucei rhodesiense sleeping sickness patients in Tororo and Busia districts, Uganda.
Odiit M, Coleman PG, McDermott JJ, Fèvre EM, Welburn SC, Woolhouse ME. Odiit M, et al. Trans R Soc Trop Med Hyg. 2004 Oct;98(10):569-76. doi: 10.1016/j.trstmh.2003.12.012. Trans R Soc Trop Med Hyg. 2004. PMID: 15289093 - Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases.
Odiit M, Coleman PG, Liu WC, McDermott JJ, Fèvre EM, Welburn SC, Woolhouse ME. Odiit M, et al. Trop Med Int Health. 2005 Sep;10(9):840-9. doi: 10.1111/j.1365-3156.2005.01470.x. Trop Med Int Health. 2005. PMID: 16135190 - [Human African trypanosomiasis].
Dumas M, Bouteille B. Dumas M, et al. C R Seances Soc Biol Fil. 1996;190(4):395-408. C R Seances Soc Biol Fil. 1996. PMID: 8952890 Review. French. - Trypanosoma brucei infection in a HIV positive Ugandan male.
Dill EA, Renault C, Kirkpatrick BD. Dill EA, et al. Clin Lab Sci. 2011 Spring;24(2):85-8. Clin Lab Sci. 2011. PMID: 21657140 - Priorities for the elimination of sleeping sickness.
Welburn SC, Maudlin I. Welburn SC, et al. Adv Parasitol. 2012;79:299-337. doi: 10.1016/B978-0-12-398457-9.00004-4. Adv Parasitol. 2012. PMID: 22726645 Review.
Cited by
- Morphological changes, nitric oxide production, and phagocytosis are triggered in vitro in microglia by bloodstream forms of Trypanosoma brucei.
Figarella K, Uzcategui NL, Mogk S, Wild K, Fallier-Becker P, Neher JJ, Duszenko M. Figarella K, et al. Sci Rep. 2018 Oct 9;8(1):15002. doi: 10.1038/s41598-018-33395-x. Sci Rep. 2018. PMID: 30302029 Free PMC article. - Epidemiology of human African trypanosomiasis.
Franco JR, Simarro PP, Diarra A, Jannin JG. Franco JR, et al. Clin Epidemiol. 2014 Aug 6;6:257-75. doi: 10.2147/CLEP.S39728. eCollection 2014. Clin Epidemiol. 2014. PMID: 25125985 Free PMC article. Review. - Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in Uganda.
Hackett F, Berrang Ford L, Fèvre E, Simarro P. Hackett F, et al. PLoS Negl Trop Dis. 2014 Feb 13;8(2):e2704. doi: 10.1371/journal.pntd.0002704. eCollection 2014 Feb. PLoS Negl Trop Dis. 2014. PMID: 24551264 Free PMC article. - Prevalence and types of coinfections in sleeping sickness patients in kenya (2000/2009).
Kagira JM, Maina N, Njenga J, Karanja SM, Karori SM, Ngotho JM. Kagira JM, et al. J Trop Med. 2011;2011:248914. doi: 10.1155/2011/248914. Epub 2011 Sep 11. J Trop Med. 2011. PMID: 21915184 Free PMC article. - Estimates of the duration of the early and late stage of gambiense sleeping sickness.
Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F. Checchi F, et al. BMC Infect Dis. 2008 Feb 8;8:16. doi: 10.1186/1471-2334-8-16. BMC Infect Dis. 2008. PMID: 18261232 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous